Companies /Healthcare

Pfizer Inc

NYSE: PFE Drug Manufacturers - General
$29.64
▲ $0.43 (+1.47%) today
Markets open · 12:25pm ET

PFE Coverage Page 34

7:05am ET
Investing

The 5 Most Shorted Dow Stocks

As of the most recently reported period, short sellers still favored Microsoft, Intel and Pfizer above all other Dow stocks.

Trey Thoelcke
7:05am ET
Investing

5 Most Shorted Dow Stocks

As of the most recently reported period, short sellers favored Microsoft, Intel and Pfizer above all other Dow stocks.

Trey Thoelcke
9:55am ET
Health and Healthcare

Good News for Teens Suffering Atopic Dermatitis

Pfizer has announced positive top-line results from a second Phase 3 pivotal study evaluating abrocitinib, in patients aged 12 and older with moderate to severe atopic dermatitis.

PFE
Chris Lange